Nektar Therapeutics Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| BVF INC/IL | 11/14/2025 | 1.28 M | $72.64 M | 100.00% | 9.06% |
| VANGUARD GROUP INC | 11/07/2025 | 948.65 K | $53.98 M | 30.04% | 6.73% |
| MORGAN STANLEY | 11/14/2025 | 929.15 K | $52.87 M | 1,188.00% | 6.60% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2025 | 924.90 K | $52.63 M | 316.82% | 6.57% |
| FARALLON CAPITAL MANAGEMENT LLC | 11/14/2025 | 791.00 K | $45.01 M | 100.00% | 5.62% |
| BLACKROCK, INC. | 11/12/2025 | 609.11 K | $34.66 M | 46.69% | 4.32% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2025 | 548.20 K | $31.19 M | -14.38% | 3.89% |
| MILLENNIUM MANAGEMENT LLC | 11/14/2025 | 545.99 K | $31.07 M | -15.88% | 3.88% |
| TWO SIGMA INVESTMENTS, LP | 11/14/2025 | 434.24 K | $24.71 M | 446.93% | 3.08% |
| NANTAHALA CAPITAL MANAGEMENT, LLC | 11/14/2025 | 418.52 K | $23.81 M | -41.03% | 2.97% |
| CITADEL ADVISORS LLC | 11/14/2025 | 361.07 K | $20.55 M | 100.00% | 2.56% |
| CITADEL ADVISORS LLC | 11/14/2025 | 353.73 K | $20.13 M | 23.86% | 2.51% |
| 22NW, LP | 11/14/2025 | 331.12 K | $18.84 M | 126.61% | 2.35% |
| EMERALD ADVISERS, LLC | 10/30/2025 | 323.25 K | $18.39 M | 100.00% | 2.29% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2025 | 311.00 K | $17.70 M | -30.92% | 2.21% |
| JEFFERIES FINANCIAL GROUP INC. | 11/13/2025 | 303.20 K | $17.25 M | 100.00% | 2.15% |
| GREAT POINT PARTNERS LLC | 11/14/2025 | 300.00 K | $17.07 M | 100.00% | 2.13% |
| PRIMECAP MANAGEMENT CO/CA/ | 11/12/2025 | 289.05 K | $16.45 M | -3.56% | 2.05% |
| RENAISSANCE TECHNOLOGIES LLC | 11/13/2025 | 278.54 K | $15.85 M | 12.74% | 1.98% |
| ARMISTICE CAPITAL, LLC | 11/17/2025 | 268.00 K | $15.25 M | 116.13% | 1.90% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 10/30/2025 | 233.21 K | $13.27 M | 100.00% | 1.66% |
| WOODLINE PARTNERS LP | 11/14/2025 | 233.06 K | $13.26 M | -5.32% | 1.65% |
| INVESCO LTD. | 11/13/2025 | 226.90 K | $12.91 M | 608.34% | 1.61% |
| GEODE CAPITAL MANAGEMENT, LLC | 11/12/2025 | 225.24 K | $12.82 M | 70.15% | 1.60% |
| GILDER GAGNON HOWE & CO LLC | 11/14/2025 | 224.83 K | $12.79 M | 677.90% | 1.60% |
| BALYASNY ASSET MANAGEMENT L.P. | 11/14/2025 | 182.81 K | $10.40 M | -52.67% | 1.30% |
| TWO SIGMA ADVISERS, LP | 11/14/2025 | 178.91 K | $10.18 M | 100.00% | 1.27% |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC | 11/14/2025 | 171.78 K | $9.77 M | 100.00% | 1.22% |
| NATIONALE-NEDERLANDEN POWSZECHNE TOWARZYSTWO EMERYTALNE S.A. | 11/12/2025 | 153.85 K | $8.75 M | 100.00% | 1.09% |
| CITADEL ADVISORS LLC | 11/14/2025 | 134.28 K | $7.64 M | -36.14% | 0.95% |
| STATE STREET CORP | 11/14/2025 | 129.00 K | $7.34 M | 157.46% | 0.92% |
| BOXER CAPITAL MANAGEMENT, LLC | 11/14/2025 | 125.00 K | $7.11 M | 0.00% | 0.89% |
| POINT72 ASSET MANAGEMENT, L.P. | 11/14/2025 | 123.66 K | $7.04 M | 100.00% | 0.88% |
| SOFINNOVA INVESTMENTS, INC. | 11/14/2025 | 118.42 K | $6.74 M | 100.00% | 0.84% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 11/10/2025 | 114.66 K | $6.52 M | 73.92% | 0.81% |
| QUINN OPPORTUNITY PARTNERS LLC | 11/13/2025 | 109.87 K | $6.25 M | 100.00% | 0.78% |
| HUDSON BAY CAPITAL MANAGEMENT LP | 11/13/2025 | 107.68 K | $6.13 M | 100.00% | 0.76% |
| FRED ALGER MANAGEMENT, LLC | 11/14/2025 | 91.81 K | $5.22 M | 74.17% | 0.65% |
| TREXQUANT INVESTMENT LP | 11/14/2025 | 91.48 K | $5.21 M | 100.00% | 0.65% |
| UBS GROUP AG | 11/13/2025 | 90.82 K | $5.17 M | -54.90% | 0.64% |
| DEUTSCHE BANK AG\ | 11/13/2025 | 90.00 K | $5.12 M | 100.00% | 0.64% |
| SIMPLIFY ASSET MANAGEMENT INC. | 10/20/2025 | 87.17 K | $4.96 M | 67.65% | 0.62% |
| STONEPINE CAPITAL MANAGEMENT, LLC | 11/13/2025 | 85.00 K | $4.84 M | 69.32% | 0.60% |
| EAM INVESTORS, LLC | 11/14/2025 | 78.21 K | $4.40 M | 223.77% | 0.56% |
| CAPTION MANAGEMENT, LLC | 11/14/2025 | 77.50 K | $4.41 M | 100.00% | 0.55% |
| GOLDMAN SACHS GROUP INC | 11/14/2025 | 77.06 K | $4.38 M | 23.39% | 0.55% |
| SIMPLEX TRADING, LLC | 11/12/2025 | 76.45 K | $4.35 M | 62.82% | 0.54% |
| DIADEMA PARTNERS LP | 11/14/2025 | 75.00 K | $4.27 M | 100.00% | 0.53% |
| MOODY ALDRICH PARTNERS LLC | 10/21/2025 | 73.72 K | $4.19 M | 62.33% | 0.52% |
| WOLVERINE TRADING, LLC | 11/14/2025 | 73.50 K | $4.33 M | 47.00% | 0.52% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Nektar Therapeutics institutional Ownership - FAQ's
During the previous two years, 280 institutional investors and hedge funds held shares of Nektar Therapeutics. The most heavily invested institutionals were:
BVF INC/IL: 1.28 M
VANGUARD GROUP INC: 948,647
MORGAN STANLEY: 929,151
SUSQUEHANNA INTERNATIONAL GROUP, LLP: 924,896
FARALLON CAPITAL MANAGEMENT LLC: 791,000
BlackRock, Inc.: 609,114
102.25% of Nektar Therapeutics stock is owned by institutional investors.
Institutional investors have bought a total of 77.85 M shares in the last 24 months. This purchase volume represents approximately $4.71 B in transactions.